Novartis Korea draws fire

Published: 2013-05-30 06:58:00

Updated: 2013-05-30 06:58:00

Novartis Korea’s immorality is under severe criticism from the domestic pharmaceutical industry as the company has recently announced its plan to suspend Glivec’s patient assistance program once generic drugs enter the market.

So far, the company has paid 10 percent of the prescription cost of...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK